Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC50687c-Di-AMP sodium salt纯度: >98.00%
Endogenous STING and DDX41 agonist; mediates DDX41-STING interaction
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC50165 | SM 324405 | 677773-91-0 | >98.00% | |
A TLR7 agonist | ||||
| GC50176 | PMX 53 | 219639-75-5 | >98.00% / >99.50% | |
PMX 53是一种高效且具有细胞渗透性和口服活性的C5a受体(CD88)拮抗剂,IC 50 值为20nM。 | ||||
| GC50190 | Fenretinide - d4 | 2118244-64-5 | - | |
An internal standard for the quantification of fenretinide | ||||
| GC50238 | PMX 53c | - | - | |
Negative control for PMX 53 | ||||
| GC50241 | M62812 | 613263-00-6 | - | |
TLR-4 inhibitor | ||||
| GC50242 | RA 839 | 1832713-02-6 | - | |
RA 839 是 Keap1 的非共价小分子结合剂,Kd 约为 6 μM,是 Nrf2 信号传导的选择性激活剂。 | ||||
| GC50243 | NFAT inhibitor, Cell Permeable | 592517-80-1 | - | |
A cell-permeable form of NFAT inhibitor | ||||
| GC50253 | PF 543 hydrochloride | 1706522-79-3 | >98.00% | |
A potent inhibitor of SPHK1 | ||||
| GC50280 | JX 06 | 729-46-4 | >99.50% | |
An irreversible PDHK inhibitor | ||||
| GC50292 | c-Di-GMP sodium salt | - | - | |
Endogenous STING and DDX41 agonist; activates STING-dependent signaling | ||||
| GC50296 | D9 | 1527513-89-8 | - | |
D9 是一种有效的选择性硫氧还蛋白还原酶 (TrxR) 抑制剂,EC50 为 2.8 nM。 D9 具有在体外和体内抑制肿瘤增殖的能力。 | ||||
| GC50297 | RS 09 | 1449566-36-2 | >99.50% | |
RS 09是一种能够激活TLR-4信号通路的合成肽。RS 09可以作为佐剂增强BALB/c小鼠的免疫反应。 | ||||
| GC50342 | CP 424174 | 210825-31-3 | - | |
An inhibitor of stimulus-coupled IL-1β post-translational processing | ||||
| GC50350 | TC JL 37 | 1258294-34-6 | - | |
TC JL 37 是一种有效的、选择性的、可口服的 TYK2 抑制剂,Ki 为 1.6 nM。 | ||||
| GC50356 | CL 075 | 256922-53-9 | >99.00% | |
CL 075 (3M002) 是一种具有免疫调节特性的选择性 TLR8 激动剂。 | ||||
| GC50374 | TH 1020 | 1841460-82-9 | >99.50% | |
TH 1020是一种Toll样受体5(TLR5)/鞭毛蛋白复合物拮抗剂,IC 50 值为0.85μM。 | ||||
| GC50422 | 10-Cl-BBQ | 23982-76-5 | - | |
Potent aryl hydrocarbon receptor (AhR) agonist; orally bioavailable | ||||
| GC50511 | UCLA GP130 2 | 339303-87-6 | >99.50% | |
A humanin peptide mimetic | ||||
| GC50556 | NBC 19 | 2068818-75-5 | - | |
Potent NLRP3 inflammasome inhibitor | ||||
| GC50569 | NLRP3-IN-2 | 16673-34-0 | >98.50% | |
An NLRP3 inflammasome inhibitor | ||||
| GC50611 | NBC 6 | 2068818-02-8 | >99.00% | |
NBC 6 是一种有效的、选择性的 NLRP3 炎性体抑制剂 (IC50= 574 nM),其作用独立于 Ca2+。 | ||||
| GC50687 | c-Di-AMP sodium salt | - | >98.00% | |
Endogenous STING and DDX41 agonist; mediates DDX41-STING interaction | ||||
| GC52002 | Emavusertib | 1801344-14-8 | >99.00% | |
An IRAK4 inhibitor | ||||
| GC52007 | N-hydroxylamine Dapsone | 32695-27-5 | >98.00% | |
An active metabolite of dapsone | ||||
